More about

Chemotherapy

News
October 02, 2024
3 min read
Save

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

The American Heart Association Scientific Sessions will be held in-person only in Chicago from Nov. 16 to 18 and will feature eight late-breaking science sessions during the 3-day meeting.

News
October 02, 2024
3 min read
Save

‘Be very suspicious’: Staging of early pancreatic cancer inaccurate up to 80% of the time

‘Be very suspicious’: Staging of early pancreatic cancer inaccurate up to 80% of the time

Nearly 80% of individuals clinically diagnosed with stage I pancreatic ductal adenocarcinoma and close to 30% diagnosed with stage II disease got upstaged after surgery, according to retrospective study results.

News
September 30, 2024
3 min read
Save

Shorter course of radiation after mastectomy does not compromise breast reconstruction

Shorter course of radiation after mastectomy does not compromise breast reconstruction

Women who want breast reconstruction after mastectomy can undergo a shorter radiation therapy regimen without significantly increasing their risk for complications, according to results of a randomized phase 3 trial.

News
September 28, 2024
1 min read
Save

Gynecologic Cancer Awareness Month: Regimens extend survival; talc linked to ovarian cancer

Gynecologic Cancer Awareness Month: Regimens extend survival; talc linked to ovarian cancer

September is Gynecologic Cancer Awareness Month.

News
September 26, 2024
3 min read
Save

Trial of CAR-T for prostate cancer takes steps toward ‘potentially curative’ therapy

Trial of CAR-T for prostate cancer takes steps toward ‘potentially curative’ therapy

Chimeric antigen receptor T-cell therapy exhibited activity with minimal adverse effects for men with advanced prostate cancer, findings of a first-in-human trial showed.

News
September 23, 2024
1 min read
Save

Datopotamab deruxtecan fails to extend OS vs. chemotherapy in advanced breast cancer

Datopotamab deruxtecan fails to extend OS vs. chemotherapy in advanced breast cancer

Datopotamab deruxtecan failed to extend OS vs. chemotherapy for adults with advanced breast cancer, according to the agent’s manufacturer.

News
September 23, 2024
3 min read
Save

Older cancer survivors at elevated risk for cardiovascular disease

Older cancer survivors at elevated risk for cardiovascular disease

Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.

News
September 20, 2024
1 min read
Save

FDA approves Rybrevant for advanced lung cancer

FDA approves Rybrevant for advanced lung cancer

The FDA approved amivantamab-vmjw in combination with standard chemotherapy for the treatment of certain adults with non-small cell lung cancer, according to the agent’s manufacturer.

News
September 20, 2024
3 min read
Save

Novel occupational medicine initiative helps patients balance work with cancer treatment

Novel occupational medicine initiative helps patients balance work with cancer treatment

Approximately half of the 18 million cancer survivors in the United States are of working age.

News
September 18, 2024
1 min read
Save

Patritumab deruxtecan extends PFS vs. chemotherapy in advanced non-small cell lung cancer

Patritumab deruxtecan extends PFS vs. chemotherapy in advanced non-small cell lung cancer

Patritumab deruxtecan improved PFS compared with chemotherapy among certain patients with advanced non-small cell lung cancer, according to the agent’s manufacturer.

View more